National Institute for Health and Care Excellence
NICE rejects Enhertu for HER2-low breast cancer over cost concerns
Anika Sharma
The remarkable efficacy data that initially earned AstraZeneca and Daiichi Sankyo’s Enhertu a standing ovation at the ASCO meeting last ...
Eli Lilly’s Mounjaro gets NICE approval for type 2 diabetes after cost-effectiveness review
Anika Sharma
Eli Lilly’s diabetes medication, Mounjaro (tirzepatide), has been on a winning streak since its US launch in May, and now ...
National Institute for Health and Care Excellence remains skeptical about the effectiveness of Mounjaro for diabetes
SG Tylor
Eli Lilly has received positive data for its experimental obesity therapies, but in the UK, it faced a setback as ...
